Skip to main content
Canna~Fangled Abstracts

Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming

By September 21, 2021September 23rd, 2021No Comments

 

. 2021 Sep 21.

doi: 10.1038/s41385-021-00455-x.

Online ahead of print.
Alba Angelina 1, Mario Pérez-Diego 1, Jacobo López-Abente 1, Beate Rückert 2, Ivan Nombela 1, Mübeccel Akdis 2, Mar Martín-Fontecha 3, Cezmi Akdis 2, Oscar Palomares 4
Affiliations 

Abstract

The generation of functional regulatory T cells (Tregs) is essential to keep tissue homeostasis and restore healthy immune responses in many biological and inflammatory contexts. Cannabinoids have been pointed out as potential therapeutic tools for several diseases. Dendritic cells (DCs) express the endocannabinoid system, including the cannabinoid receptors CB1 and CB2. However, how cannabinoids might regulate functional properties of DCs is not completely understood. We uncover that the triggering of cannabinoid receptors promote human tolerogenic DCs that are able to prime functional FOXP3+ Tregs in the context of different inflammatory diseases. Mechanistically, cannabinoids imprint tolerogenicity in human DCs by inhibiting NF-κB, MAPK and mTOR signalling pathways while inducing AMPK and functional autophagy flux via CB1- and PPARα-mediated activation, which drives metabolic rewiring towards increased mitochondrial activity and oxidative phosphorylation. Cannabinoids exhibit in vivo protective and anti-inflammatory effects in LPS-induced sepsis and also promote the generation of FOXP3+ Tregs. In addition, immediate anaphylactic reactions are decreased in peanut allergic mice and the generation of allergen-specific FOXP3+ Tregs are promoted, demonstrating that these immunomodulatory effects take place in both type 1- and type 2-mediated inflammatory diseases. Our findings might open new avenues for novel cannabinoid-based interventions in different inflammatory and immune-mediated diseases.

References

    1. Wculek, S. K. et al. Dendritic cells in cancer immunology and immunotherapy. Nat. Rev. Immunol. 20, 7–24 (2020). – PubMed – DOI
    1. Lucca, L. E. & Dominguez-Villar, M. Modulation of regulatory T cell function and stability by co-inhibitory receptors. Nat. Rev. Immunol.20, 680–693 (2020).
    1. Wing, J. B., Tay, C. & Sakaguchi, S. Control of regulatory T cells by co-signal molecules. Adv. Exp. Med. Biol. 1189, 179–210 (2019). – PubMed – DOI
    1. Palomares, O., Akdis, M., Martin-Fontecha, M. & Akdis, C. A. Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells. Immunol. Rev. 278, 219–236 (2017). – PubMed – DOI
    1. Abbas, A. K. et al. Regulatory T cells: recommendations to simplify the nomenclature. Nat. Immunol. 14, 307–308 (2013). – PubMed – DOI – PMC

 

Leave a Reply